Lista de obras - Jonatan Ising Bagger - Dominio Público Uruguay

Circulating Levels of the Soluble Receptor for AGE (sRAGE) during Escalating Oral Glucose Dosages and Corresponding Isoglycaemic i.v. Glucose Infusions in Individuals with and without Type 2 Diabetes

artículo científico publicado en 2020

Determinants of Fasting Hyperglucagonemia in Patients with Type 2 Diabetes and Nondiabetic Control Subjects

artículo científico publicado en 2018

Diabetic Ketoacidosis in a Patient with Type 2 Diabetes After Initiation of Sodium-Glucose Cotransporter 2 Inhibitor Treatment

artículo científico publicado en 2015

Effect of Oxyntomodulin, Glucagon, GLP-1, and Combined Glucagon +GLP-1 Infusion on Food Intake, Appetite, and Resting Energy Expenditure

artículo científico publicado en 2015

Effects of Smoking Versus Nonsmoking on Postprandial Glucose Metabolism in Heavy Smokers Compared With Nonsmokers

artículo científico publicado en 2018

Erratum. Evidence of Extrapancreatic Glucagon Secretion in Man. Diabetes 2016;65:585-597

artículo científico publicado en 2016

Evidence of Extrapancreatic Glucagon Secretion in Man

article

Glucagon and type 2 diabetes: the return of the alpha cell.

artículo científico publicado en 2014

Glucagon responses to increasing oral loads of glucose and corresponding isoglycaemic intravenous glucose infusions in patients with type 2 diabetes and healthy individuals

article

Glucose-lowering effects and low risk of hypoglycemia in patients with maturity-onset diabetes of the young when treated with a GLP-1 receptor agonist: a double-blind, randomized, crossover trial

artículo científico publicado en 2014

Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals

artículo científico publicado en 2019

Higher Endogenous Glucose Production During OGTT vs Isoglycemic Intravenous Glucose Infusion

artículo científico publicado en 2016

Impaired beta cell sensitivity to incretins in type 2 diabetes is insufficiently compensated by higher incretin response.

artículo científico publicado en 2017

Impaired incretin-induced amplification of insulin secretion after glucose homeostatic dysregulation in healthy subjects.

artículo científico publicado en 2012

Impaired regulation of the incretin effect in patients with type 2 diabetes

artículo científico publicado en 2011

Increased postprandial GIP and glucagon responses, but unaltered GLP-1 response after intervention with steroid hormone, relative physical inactivity, and high-calorie diet in healthy subjects

artículo científico publicado en 2010

Incretin effect and glucagon responses to oral and intravenous glucose in patients with maturity-onset diabetes of the young--type 2 and type 3.

artículo científico publicado en 2014

Involvement of steatosis-induced glucagon resistance in hyperglucagonaemia

artículo científico publicado en 2015

Is glucagon-like peptide-1 fully protected by the dipeptidyl peptidase 4 inhibitor sitagliptin when administered to patients with type 2 diabetes?

artículo científico publicado en 2018

Mathematical Modelling of Glucose-Dependent Insulinotropic Polypeptide and Glucagon-like Peptide-1 following Ingestion of Glucose

artículo científico publicado en 2017

Mechanism-Based Modeling of Gastric Emptying Rate and Gallbladder Emptying in Response to Caloric Intake

artículo científico publicado en 2016

Mechanisms of the incretin effect in subjects with normal glucose tolerance and patients with type 2 diabetes

artículo científico publicado en 2013

One Year's Treatment with the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide Decreases Hepatic Fat Content in Women with Nonalcoholic Fatty Liver Disease and Prior Gestational Diabetes Mellitus in a Randomized, Placebo-Controlled Trial

artículo científico publicado en 2020

Physiological and pathophysiological aspects of incretin hormones and glucagon

artículo científico publicado en 2017

Postprandial incretin and islet hormone responses and dipeptidyl-peptidase 4 enzymatic activity in patients with maturity onset diabetes of the young

artículo científico publicado en 2015

Reduced glucose tolerance and insulin resistance induced by steroid treatment, relative physical inactivity, and high-calorie diet impairs the incretin effect in healthy subjects.

artículo científico publicado en 2010

Reduced postprandial GLP-1 responses in women with gestational diabetes mellitus

article

Semimechanistic model describing gastric emptying and glucose absorption in healthy subjects and patients with type 2 diabetes.

artículo científico publicado en 2015

The Effects of Dual GLP-1/GIP Receptor Agonism on Glucagon Secretion-A Review ⬇️

artículo científico

The alpha-cell as target for type 2 diabetes therapy.

artículo científico publicado en 2011

The separate and combined impact of the intestinal hormones, GIP, GLP-1, and GLP-2, on glucagon secretion in type 2 diabetes

artículo científico publicado en 2011

Therapy for obesity based on gastrointestinal hormones

artículo científico publicado en 2011

Women with prior gestational diabetes mellitus and prediabetes are characterised by a decreased incretin effect

artículo científico publicado en 2017

[Classification of duties in surgical wards] ⬇️

artículo científico publicado en 2014

Lista de obras de Jonatan Ising Bagger

Circulating Levels of the Soluble Receptor for AGE (sRAGE) during Escalating Oral Glucose Dosages and Corresponding Isoglycaemic i.v. Glucose Infusions in Individuals with and without Type 2 Diabetes

Determinants of Fasting Hyperglucagonemia in Patients with Type 2 Diabetes and Nondiabetic Control Subjects

Diabetic Ketoacidosis in a Patient with Type 2 Diabetes After Initiation of Sodium-Glucose Cotransporter 2 Inhibitor Treatment

Effect of Oxyntomodulin, Glucagon, GLP-1, and Combined Glucagon +GLP-1 Infusion on Food Intake, Appetite, and Resting Energy Expenditure

Effects of Smoking Versus Nonsmoking on Postprandial Glucose Metabolism in Heavy Smokers Compared With Nonsmokers

Erratum. Evidence of Extrapancreatic Glucagon Secretion in Man. Diabetes 2016;65:585-597

Evidence of Extrapancreatic Glucagon Secretion in Man

Glucagon and type 2 diabetes: the return of the alpha cell.

Glucagon responses to increasing oral loads of glucose and corresponding isoglycaemic intravenous glucose infusions in patients with type 2 diabetes and healthy individuals

Glucose-lowering effects and low risk of hypoglycemia in patients with maturity-onset diabetes of the young when treated with a GLP-1 receptor agonist: a double-blind, randomized, crossover trial

Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals

Higher Endogenous Glucose Production During OGTT vs Isoglycemic Intravenous Glucose Infusion

Impaired beta cell sensitivity to incretins in type 2 diabetes is insufficiently compensated by higher incretin response.

Impaired incretin-induced amplification of insulin secretion after glucose homeostatic dysregulation in healthy subjects.

Impaired regulation of the incretin effect in patients with type 2 diabetes

Increased postprandial GIP and glucagon responses, but unaltered GLP-1 response after intervention with steroid hormone, relative physical inactivity, and high-calorie diet in healthy subjects

Incretin effect and glucagon responses to oral and intravenous glucose in patients with maturity-onset diabetes of the young--type 2 and type 3.

Involvement of steatosis-induced glucagon resistance in hyperglucagonaemia

Is glucagon-like peptide-1 fully protected by the dipeptidyl peptidase 4 inhibitor sitagliptin when administered to patients with type 2 diabetes?

Mathematical Modelling of Glucose-Dependent Insulinotropic Polypeptide and Glucagon-like Peptide-1 following Ingestion of Glucose

Mechanism-Based Modeling of Gastric Emptying Rate and Gallbladder Emptying in Response to Caloric Intake

Mechanisms of the incretin effect in subjects with normal glucose tolerance and patients with type 2 diabetes

One Year's Treatment with the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide Decreases Hepatic Fat Content in Women with Nonalcoholic Fatty Liver Disease and Prior Gestational Diabetes Mellitus in a Randomized, Placebo-Controlled Trial

Physiological and pathophysiological aspects of incretin hormones and glucagon

Postprandial incretin and islet hormone responses and dipeptidyl-peptidase 4 enzymatic activity in patients with maturity onset diabetes of the young

Reduced glucose tolerance and insulin resistance induced by steroid treatment, relative physical inactivity, and high-calorie diet impairs the incretin effect in healthy subjects.

Reduced postprandial GLP-1 responses in women with gestational diabetes mellitus

Semimechanistic model describing gastric emptying and glucose absorption in healthy subjects and patients with type 2 diabetes.

The Effects of Dual GLP-1/GIP Receptor Agonism on Glucagon Secretion-A Review ⬇️

The alpha-cell as target for type 2 diabetes therapy.

The separate and combined impact of the intestinal hormones, GIP, GLP-1, and GLP-2, on glucagon secretion in type 2 diabetes

Therapy for obesity based on gastrointestinal hormones

Women with prior gestational diabetes mellitus and prediabetes are characterised by a decreased incretin effect

[Classification of duties in surgical wards] ⬇️